Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Cochlear Limited ( (AU:COH) ) has shared an update.
Cochlear Limited has announced a new application for the quotation of securities on the Australian Securities Exchange. This involves the issuance of ordinary fully paid securities as part of an employee incentive scheme, indicating a commitment to reward and retain its workforce. The announcement reflects Cochlear’s strategic efforts to enhance its market position by investing in its human capital, which can have positive implications for its stakeholders and industry standing.
More about Cochlear Limited
Cochlear Limited operates in the medical device industry, specializing in implantable hearing solutions. The company is known for its cochlear implants, bone conduction implants, and acoustic implants, focusing on improving hearing for individuals with hearing loss.
YTD Price Performance: 13.09%
Average Trading Volume: 83
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: $12.84B
For a thorough assessment of COH stock, go to TipRanks’ Stock Analysis page.
